Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection

NCT05330455 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

74

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated as a strategic decision

Conditions

Hepatitis B

Interventions

DRUG: GSK3965193
DRUG: Placebo to match GSK3965193
DRUG: Bepirovirsen

Sponsor

GlaxoSmithKline